Global Opioids Market Trends, Analysis, Growth, and Forecast: 2018 to 2027

Global Opioids Market Overview:

“The global Opioids Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”

Request Covid - 19 Impact

Opioids are psychoactive chemicals that occurs naturally or can be made in laboratory. Opioids are the drug that acts on the nerve system in order to relieve pain, the drug chemically interact with opioid receptors on nerve cells in the body and brain. Opioids are pain relievers which are generally safe when taken for short period of time as prescribed by the doctor.

However, if taken in large quantity it leads to dependence and increases rise of mortality in patients. Opioids are used to treat moderate to severe pain that does not respond well to other pain medicine. Opioids are available in various dosage forms such as liquids, transdermal patches, lozenges, pills.

Increasing incidence of chronic diseases is expected to gain traction over the forecast period. According to Centers for Disease Control and Prevention as of 2012, 117 million people in US had one or more chronic health conditions such as stroke, heart disease, cancer, type 2 diabetes, obesity which in turn is expected to create demand for opioids drugs over the forecast period. Increasing number of generic approvals by health authorities of various countries is other factor contributing to growth of the global opioids market.

Stringent government regulation on prescription of opioids drugs is major factors restraining the growth of the global opioids market.

North America market dominates the global opioids market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to key manufacturer operating in the region and increasing incidence of chronic diseases in the region. Europe accounts for second-largest revenue share contribution to the global ocular surgery market, followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. The market in Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years, owing to increasing prevalence of cancer and orthopedic disease.

Global opioids market segmentation;

By drug class:

• Agonist
  • Codeine
  • Fentanyl
  • Meperidine
  • Methadone
  • Morphine
  • Hydrocodone
  • Diphenoxylate
  • Hydromorphone
  • Methylphenidate
  • Oxycodone
  • Oxymorphone
• Antagonist
  • Buprenorphine
  • Naloxone
  • Naltrexone
  • Methylnaltrexone
  • Nalbuphine

By therapeutic application:

• Pain Management
  • Neuropathic Pain
  • Migraine
  • Back Pain
  • Osteoarthritis Pain
  • Cancer Pain
  • Others
• Diarrhea Treatment
• Cough Treatment

By region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa